About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘nature publishing group’ Category

Faulty model forces rapid retraction of paper on sea ice and climate change

with 4 comments

natgeosciLast month, researchers published a paper whose conclusions suggested that looking at Arctic sea ice in the autumn offers clues to winter temperatures in Europe.

The letter appeared — briefly, as this post will demonstrate — in Nature Geoscience. The letter, titled “High predictability of the winter Euro–Atlantic climate from cryospheric variability,” was written by Javier Garcia-Serrano and Claude Frankignoul, of the Université Pierre et Marie Curie. The journal published the letter on March 23 and retracted it on April 14.

Here’s the abstract, which can still be found online:

Read the rest of this entry »

About these ads

Brutal honesty: Author takes to PubPeer to announce retraction — and tells us she’ll lose PhD, professorship

with 43 comments

Eriko Suzuki

Eriko Suzuki

Over the past week, there have been a number of comments on PubPeer — a site of which we’re big fans — about a 2007 paper in Oncogene.

The comments suggested that the figures in the paper had problems. Some bands seemed to be duplicated, and one of the images looked very much like that of another paper.

Then, today, first author Eriko Suzuki left this comment: Read the rest of this entry »

Nature corrects a correction

with 13 comments

nature 4 9 14Last year, we reported on a Nature correction of a paper for what a McGill University committee had earlier called “intentionally contrived and falsified” figures. It turns out that the correction — like the original paper — left some Nature readers puzzled, so the journal has run a correction of the correction: Read the rest of this entry »

Written by ivanoransky

April 14, 2014 at 9:30 am

Lack of citation prompts correction in Nature journal

with 24 comments

nature communicationsIt’s not unusual to hear authors bemoan the fact that a new paper doesn’t cite their work that set the stage for a scientific advance. “The journal limited me to [a seemingly abitrary number of] references,” authors sometimes shrug, with or without apology. This week, however, we found a case of that which seems to have been resolved to everyone’s satisfaction.

The authors of a September 2013 article in Nature Communications have issued a correction for the piece, which failed to cite the source of a key step in their experiment.

The article, “Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction,” came from the lab of William “Clay” Bracken, a biochemist at Weill Cornell Medical College. According to the abstract: Read the rest of this entry »

Novartis Diovan scandal claims two more papers

with 5 comments

diabetes careA complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other.

Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.

Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”

Read the rest of this entry »

“I am deeply saddened and disturbed:” Co-author of retracted Nature paper reveals how problems came to light

with 40 comments

Ben Scheres

Ben Scheres

On Wednesday, we reported on a Nature retraction of a paper whose corresponding author had also had a Cell paper retracted, and had been found to have committed a “violation of academic integrity” by Utrecht University. Today, we present the back story of how those retractions came to be, from another co-author of both papers, Ben Scheres, of Wageningen University: Read the rest of this entry »

Nature paper by researcher found to have violated academic integrity retracted

with 4 comments


Pankaj Dhonukshe

A 2013 paper in Nature that was among those whose first or last author had committed a “violation of academic integrity,” according to Utrecht University, has been retracted.

Here’s the notice: for “CLASP-mediated cortical microtubule organization guides PIN polarization axis,” whose corresponding author was Pankaj Dhonukshe: Read the rest of this entry »

Reverse peristalsis for gut journal which disgorges Cleveland Clinic paper for plagiarism

with 3 comments

ajg_cimageThe American Journal of Gastroenterology has retracted a 2011 article on colon cancer by a group of Cleveland Clinic researchers after finding “evidence” of plagiarism in the text.

The article, a review, was titled “Molecular Pathways Underlying IBD-Associated Colorectal Neoplasia: Therapeutic Implications,” and has been cited 16 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction notice: Read the rest of this entry »

Written by amarcus41

March 12, 2014 at 1:38 pm

Co-author of controversial acid STAP stem cell papers in Nature requests retraction: report

with 17 comments

nature 2-27-14A co-author of two papers claiming to have shown how to create stem cells simply and easily has requested their retraction, the Wall Street Journal is reporting: Read the rest of this entry »

Written by ivanoransky

March 10, 2014 at 10:06 am

Nature paper retracted following multiple failures to reproduce results

with 7 comments

nature 2-27-14An international team of researchers from the NIH, Harvard, the University of Michigan, and two Chinese universities — Fourth Military Medical University and China Medical University — has retracted their 2012 paper in Nature after they — and a number of other groups — were unable to reproduce the key results.

The original abstract for “The NAD-dependent deacetylase SIRT2 is required for programmed necrosis” said that the findings

implicate SIRT2 as an important regulator of programmed necrosis and indicate that inhibitors of this deacetylase may constitute a novel approach to protect against necrotic injuries, including ischaemic stroke and myocardial infarction.

But here’s the notice, by corresponding author Toren Finkel and colleagues: Read the rest of this entry »


Get every new post delivered to your Inbox.

Join 31,347 other followers